Ekaterina I. Tarun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ekaterina I. Tarun has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Tatsiana Halavach
Belarusian State University
2 shared publications - Vladimir P. Kurchenko
Belarusian State University
2 shared publications - Aleksei Lodygin
North Caucasus Federal University
1 shared publication D I Metelitsa
1 shared publicationD. I. Metelitza
National Academy of Sciences of Belarus
1 shared publication- I. A. Bubra
Belarusian State University
1 shared publication
Latest Publications
- Open Access
- 12 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (18) , 13987
Influence of Complexation with β- and γ-Cyclodextrin on Bioactivity of Whey and Colostrum Peptides
Dairy protein hydrolysates possess a broad spectrum of bioactivity and hypoallergenic properties, as well as pronounced bitter taste. The bitterness is reduced by complexing the proteolysis products with cyclodextrins (CDs), and it is also important to study the bioactivity of the peptides in inclusion complexes. Hydrolysates of whey and colostrum proteins with extensive hydrolysis degree and their complexes with β/γ-CD were obtained in the present study, and comprehensive comparative analysis of the experimental samples was performed. The interaction of CD with peptides was confirmed via different methods. Bioactivity of the initial hydrolysates and their complexes were evaluated. Antioxidant activity (AOA) was determined by fluorescence reduction of fluorescein in the Fenton system. Antigenic properties were studied by competitive enzyme immunoassay. Antimutagenic effect was estimated in the Ames test. According to the experimental data, a 2.17/2.78-fold and 1.45/2.14-fold increase in the AOA was found in the β/γ-CD interaction with whey and colostrum hydrolysates, respectively. A 5.6/5.3-fold decrease in the antigenicity of whey peptides in complex with β/γ-CD was detected, while the antimutagenic effect in the host–guest systems was comparable to the initial hydrolysates. Thus, bioactive CD complexes with dairy peptides were obtained. Complexes are applicable as a component of specialized foods (sports, diet).
- 12 September 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (18) , 13987
Open AccessInfluence of Complexation with β- and γ-Cyclodextrin on Bioactivity of Whey and Colostrum Peptides
Dairy protein hydrolysates possess a broad spectrum of bioactivity and hypoallergenic properties, as well as pronounced bitter taste. The bitterness is reduced by complexing the proteolysis products with cyclodextrins (CDs), and it is also important to study the bioactivity of the peptides in inclusion complexes. Hydrolysates of whey and colostrum proteins with extensive hydrolysis degree and their complexes with β/γ-CD were obtained in the present study, and comprehensive comparative analysis of the experimental samples was performed. The interaction of CD with peptides was confirmed via different methods. Bioactivity of the initial hydrolysates and their complexes were evaluated. Antioxidant activity (AOA) was determined by fluorescence reduction of fluorescein in the Fenton system. Antigenic properties were studied by competitive enzyme immunoassay. Antimutagenic effect was estimated in the Ames test. According to the experimental data, a 2.17/2.78-fold and 1.45/2.14-fold increase in the AOA was found in the β/γ-CD interaction with whey and colostrum hydrolysates, respectively. A 5.6/5.3-fold decrease in the antigenicity of whey peptides in complex with β/γ-CD was detected, while the antimutagenic effect in the host–guest systems was comparable to the initial hydrolysates. Thus, bioactive CD complexes with dairy peptides were obtained. Complexes are applicable as a component of specialized foods (sports, diet).
- Open Access
- 30 October 2018
- Published by Publishing House Belorusskaya Nauka in Proceedings of the National Academy of Sciences of Belarus, Biological Series
- Vol. 63 (4) , 409-418
Description of biologically active protein hydrolysates of whey and colostrum
Изучены антиоксидантные, антимутагенные и антигенные свойства частичных гидролизатов молочной сыворотки и молозива, полученных с применением бактериальной эндопептидазы (алкалазы). Установлено, что глубина протеолиза, качественный и количественный состав белкового компонента образцов обусловливают уровень их антирадикальной активности и степень снижения индуцированного мутирования. По данным ДСН-электрофореза, гидролизат молочной сыворотки содержит расщепленные белки-аллергены, тогда как в гидролизате молозива обнаружена высокомолекулярная фракция (>10 кДа) частично расщепленных иммуноглобулинов. Протеолиз β-лактоглобулина, обладающего высоким аллергенным потенциалом, подтвержден результатами реакции иммунопреципитации. С применением ORAC-метода показано возрастание антиоксидантного действия гидролизованных молочной сыворотки и молозива в 2,8 и 5,0 раза соответственно. Эффект снижения индуцированного мутирования для гидролизата молочной сыворотки при тестировании составил 15,7–49,2 % для штамма Salmonella typhimurium ТА 98 и 18,8–52,1 % для штамма ТА 100, что превышает показатели гидролизата молозива. Получены образцы гипоаллергенных гидролизатов молочной сыворотки и молозива с подтвержденными антиоксидантными и антимутагенными свойствами.
- 30 October 2018
- Published by Publishing House Belorusskaya Nauka in Proceedings of the National Academy of Sciences of Belarus, Biological Series
- Vol. 63 (4) , 409-418
Open AccessDescription of biologically active protein hydrolysates of whey and colostrum
Изучены антиоксидантные, антимутагенные и антигенные свойства частичных гидролизатов молочной сыворотки и молозива, полученных с применением бактериальной эндопептидазы (алкалазы). Установлено, что глубина протеолиза, качественный и количественный состав белкового компонента образцов обусловливают уровень их антирадикальной активности и степень снижения индуцированного мутирования. По данным ДСН-электрофореза, гидролизат молочной сыворотки содержит расщепленные белки-аллергены, тогда как в гидролизате молозива обнаружена высокомолекулярная фракция (>10 кДа) частично расщепленных иммуноглобулинов. Протеолиз β-лактоглобулина, обладающего высоким аллергенным потенциалом, подтвержден результатами реакции иммунопреципитации. С применением ORAC-метода показано возрастание антиоксидантного действия гидролизованных молочной сыворотки и молозива в 2,8 и 5,0 раза соответственно. Эффект снижения индуцированного мутирования для гидролизата молочной сыворотки при тестировании составил 15,7–49,2 % для штамма Salmonella typhimurium ТА 98 и 18,8–52,1 % для штамма ТА 100, что превышает показатели гидролизата молозива. Получены образцы гипоаллергенных гидролизатов молочной сыворотки и молозива с подтвержденными антиоксидантными и антимутагенными свойствами.
- 20 March 2009
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 3 (1) , 71-76
Substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones as urease inhibitors
A comparative kinetic study of the inhibition of urea hydrolysis by 9 substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones (BI I–IX) has been carried out. The inhibition had reversible competitive mode; the inhibition constants K i, varied from 29 to 754 μM in dependence of structure of BI I–IX. Three BI I–IX, characterized by the K i values ranged from 29 to 82 μM, may be used as potential therapeutic agents in gastroenterology for treatment of gastroduodenal ulcers.
- 20 March 2009
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
- Vol. 3 (1) , 71-76
Substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones as urease inhibitors
A comparative kinetic study of the inhibition of urea hydrolysis by 9 substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones (BI I–IX) has been carried out. The inhibition had reversible competitive mode; the inhibition constants K i, varied from 29 to 754 μM in dependence of structure of BI I–IX. Three BI I–IX, characterized by the K i values ranged from 29 to 82 μM, may be used as potential therapeutic agents in gastroenterology for treatment of gastroduodenal ulcers.
- 25 December 2008
- Vol. 54 (5) , 588-96
[Substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones as inhibitors of urease].
A comparative kinetic study of the inhibition of urea hydrolysis by 9 substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones (BI I-IX) has been carried out. The inhibition had reversibl competitive character; the inhibition constants K(i), varied from 29 up to 754 microM in dependence of the structure of BI I-IX. Three BI I-III, having the K(i) values from 29 to 82 microM, may be used as the potential therapeutic agents for gastroenterology for treatment of stomach and duodenal ulcers.
- 25 December 2008
- Vol. 54 (5) , 588-96
[Substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones as inhibitors of urease].
A comparative kinetic study of the inhibition of urea hydrolysis by 9 substituted 1,5,6,7-tetrahydro-4H-benzimidazol-4-ones (BI I-IX) has been carried out. The inhibition had reversibl competitive character; the inhibition constants K(i), varied from 29 up to 754 microM in dependence of the structure of BI I-IX. Three BI I-III, having the K(i) values from 29 to 82 microM, may be used as the potential therapeutic agents for gastroenterology for treatment of stomach and duodenal ulcers.